Heme Oxygenase-1/Carbon Monoxide in Lung Vascular Injury
Heme Oxygenase-1/Carbon Monoxide in Lung Vascular Injury
批准号:
9212181
负责人:
MARY E CHOI
金额:
$46.93万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2020-01-31
关键词:
AddressAffectApoptosisAutophagocytosisAutophagosomeBilirubinBiological MarkersBlood VesselsCarbon MonoxideCatabolismCell DeathCell ProliferationCell modelCellsComplexCytoplasmic OrganelleCytoprotectionDataDevelopmentDiseaseEnergy-Generating ResourcesEnzymesExhibitsExperimental ModelsExplosionFerritinFutureHemeHumanHypoxiaIn VitroInflammasomeInflammatoryInjuryIntracellular MembranesLaboratoriesLungLung diseasesLysosomesMediator of activation proteinMembraneMitochondriaMusNutrientOrganellesPathogenesisPathway interactionsPatientsProcessProteinsPulmonary HypertensionRattusResearchRodentRoleSeveritiesSeverity of illnessSignal PathwayStressSystemTestingTissue ModelTissuesVascular remodelingVesicleYeastsbiological adaptation to stresscytokinediagnostic biomarkereffective therapyheme oxygenase-1human datahuman diseaseimprovedin vivoin vivo Modelinterestlung vascular injurynew therapeutic targetpre-clinicalpreventprotective effectpublic health relevancepulmonary arterial hypertension
中文摘要
描述(由申请人提供):自噬表现为通过溶酶体途径降解细胞质细胞器,涉及细胞内膜重排以将受损蛋白质或细胞器隔离在形成的膜囊泡或自噬体内。然后自噬体与溶酶体融合,在溶酶体中内容物被降解并回收,成为能量和营养的内源性来源。自噬在酵母系统中已经描述了几十年;然而,近年来我们目睹了这一领域在哺乳动物系统中的爆炸。自噬在肺部疾病中的作用知之甚少,自噬在肺动脉高压(PH)中的作用尚未得到严格的探索。我们已经获得了有趣的初步数据,人类PH和PH的实验模型表现出显着的诱导自噬。我们的实验室和其他实验室已经开始解开一氧化碳(CO)在各种细胞和组织损伤模型中发挥保护作用的机制和信号通路。重要的是,我们最近的研究表明,CO可以分别保护小鼠和大鼠免受缺氧或MCT诱导的PH,即使在PH发生后也是如此,这表明CO可能影响血管重塑过程,包括血管细胞增殖和凋亡。有趣的是,我们已经获得了初步的数据,CO调节培养的血管细胞和肺中的自噬过程。我们假设自噬代表了一种适应性应激反应,以防止PH,CO通过调节自噬来防止PH。此外,我们假设自噬调节的炎性小体可以潜在地作为预测PH严重程度的诊断生物标志物。我们将通过解决以下目标来测试假设:具体目标#1:确定CO诱导的自噬功能在实验PH中提供细胞保护的机制具体目标2:确定CO抑制实验性PH中炎性体途径的机制具体目标#3:确定CO是否抑制人PH中炎性体及其调节的细胞因子
英文摘要
DESCRIPTION (provided by applicant): Autophagy is manifested by degradation of cytoplasmic organelles via a lysosomal pathway, involving rearrangement of intracellular membranes to sequester damaged proteins or organelles within formed membrane vesicles, or autophagosomes. Autophagosomes then fuse with lysosomes where the content is degraded and recycled to become an endogenous source of energy and nutrients. Autophagy has been described in the yeast system for decades; however, we have witnessed the explosion of this field in the mammalian system in recent years. Little is known on the role of autophagy in lung disease, and the role of autophagy in pulmonary hypertension (PH) has not been rigorously explored. We have obtained intriguing preliminary data that human PH and experimental models of PH exhibit marked induction of autophagy. Our laboratory and others have started to unravel the mechanisms and signaling pathways by which carbon monoxide (CO) imparts protective effects in various models of cellular and tissue injury. Importantly, our recent study illustrates that CO can protect against hypoxia or MCT-induced PH in mice and rats, respectively, even after the development of PH suggesting that CO may affect vascular remodeling processes including vascular cell proliferation and apoptosis. Interestingly, we have obtained preliminary data that CO regulates the autophagic process both in cultured vascular cells and in the lung. We hypothesize that autophagy represents an adaptive stress response to protect against PH, and that CO prevents PH via regulating autophagy. Furthermore, we hypothesize that autophagy regulated inflammasomes can potentially serve as diagnostic biomarker in predicting severity of PH. We will test the hypothesis by addressing the following aims: Specific Aim #1: To determine the mechanism by which CO-induced autophagy functions to provide cytoprotection in experimental PH Specific Aim 2: To determine the mechanism by which CO dampens the inflammasome pathway in experimental PH Specific Aim #3: To determine whether CO inhibits inflammasome and its regulated cytokines in human PH
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2013-09
期刊:
Journal of biochemical and pharmacological research
影响因子:
--
作者:
[S. Ryter;A. Choi]
通讯作者:
S. Ryter;A. Choi
DOI:
10.1097/mcc.0000000000000427
发表时间:
2017-08
期刊:
Current opinion in critical care
影响因子:
3.3
作者:
[Harrington JS, Choi AMK, Nakahira K]
通讯作者:
Nakahira K
DOI:
10.1016/j.redox.2014.12.011
发表时间:
2015
期刊:
Redox biology
影响因子:
11.4
作者:
[Zhong H, Yin H]
通讯作者:
Yin H
HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-β1 and intervention via antioxidant pathways.
HIV 蛋白酶抑制剂利托那韦诱导肾纤维化和功能障碍:血小板衍生的 TGF-β1 的作用和通过抗氧化途径的干预。
DOI:
10.1097/qad.0000000000002516
发表时间:
2020
期刊:
AIDS (London, England)
影响因子:
--
作者:
[Laurence,Jeffrey, Elhadad,Sonia, Gostynska,Sandra, Yu,Zhongxin, Terry,Hunter, Varshney,Rohan, Fung,Kar-Ming, Choi,MaryE, Ahamed,Jasimuddin]
通讯作者:
Ahamed,Jasimuddin
DOI:
10.1155/2014/502676
发表时间:
2014
期刊:
International journal of cell biology
影响因子:
--
作者:
[Ryter SW, Mizumura K, Choi AM]
通讯作者:
Choi AM
共 6 条
Novel role of RIPK3-dependent necroptosis pathway in lung and kidney fibrosis
-
批准号:9981806
-
项目类别:
-
资助金额:$52.34万
-
财政年份:2017
-
负责人:MARY E CHOI
-
依托单位:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
-
批准号:6517739
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:7617636
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:8466956
-
项目类别:
-
资助金额:$17.84万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:8820727
-
项目类别:
-
资助金额:$19.57万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:8682805
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
-
批准号:6087959
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
-
批准号:6348753
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
-
批准号:6381798
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:7105780
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:7389536
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:8108133
-
项目类别:
-
资助金额:$44.55万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
-
批准号:6635250
-
项目类别:
-
资助金额:$25.65万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
-
批准号:6732759
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:7233270
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
TGF-beta signaling in the kidney
-
批准号:8313911
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2000
-
负责人:MARY E CHOI
-
依托单位:
Heme Oxygenase-1/Carbon Monoxide in Lung Vascular Injury
-
批准号:9004649
-
项目类别:
-
资助金额:$46.82万
-
财政年份:1999
-
负责人:MARY E CHOI
-
依托单位:
Heme Oxygenase-1/Carbon Monoxide in sepsis
-
批准号:8603269
-
项目类别:
-
资助金额:$7.83万
-
财政年份:1998
-
负责人:MARY E CHOI
-
依托单位:
Inflammasomes: Regulation and Function in Acute Lung Injury
-
批准号:9902543
-
项目类别:
-
资助金额:$50.85万
-
财政年份:1996
-
负责人:MARY E CHOI
-
依托单位:
ACTIVATION OF TGF-BETA 1 BY GLOMERULAR ENDOTHELIAL CELLS
-
批准号:3037662
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1992
-
负责人:MARY E CHOI
-
依托单位:
海外基金